
Neovantage Innovation Parks
Integrated life sciences innovation parks offering state-of-the-art R&D facilities and fully managed amenities for global companies.
Date | Investors | Amount | Round |
---|---|---|---|
* | $37.0m | Debt | |
Total Funding | 000k |
Neovantage Innovation Parks operates in the life sciences sector, providing state-of-the-art research and development (R&D) facilities and fully managed amenities to national and multinational companies. The company serves a diverse clientele, including small and medium-sized businesses (SMBs) and large corporations, primarily in the pharmaceutical and life sciences industries. Neovantage Innovation Parks is located in Genome Valley, the first systematically developed cluster for life sciences R&D and clean manufacturing activities in India. The company benefits from the Industrial Area Local Authority (IALA) status, which allows for accelerated infrastructure and development activities through a single window clearance mechanism.
The business model of Neovantage Innovation Parks revolves around leasing high-quality lab spaces and R&D facilities to life sciences companies. The company generates revenue through long-term lease agreements and partnerships with its tenants. Neovantage Innovation Parks also invests in the development of new properties and the acquisition of existing ones to expand its portfolio. The company is part of a larger investment group, Caisse de dépôt et placement du Québec (CDPQ), which held CAD 77 billion in real estate assets as of December 31, 2023.
Neovantage Innovation Parks is committed to creating fully integrated ecosystems that support the well-being of its occupiers. The campuses offer a range of world-class amenities, including managed services, to ensure a conducive environment for innovation and growth.
Keywords: life sciences, R&D facilities, Genome Valley, pharmaceutical, managed amenities, SMBs, multinational companies, real estate, innovation parks, CDPQ.